SSRIs and Kids: Escitalopram for Pediatric Anxiety

David Rosenberg, M.D., a distinguished researcher in pediatric anxiety treatments, discusses the promising role of escitalopram in managing generalized anxiety disorder in children. The conversation highlights a groundbreaking clinical trial showcasing escitalopram's efficacy compared to placebo. Rosenberg stresses the medication's safety, particularly for kids aged 7 to 11, and its potential to prevent future depression. This innovative approach could significantly reshape how we treat anxiety in young patients and emphasizes the need for combining medication with therapy.